Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$6.5 million.

  • Bioharvest Sciences' Operating Expenses fell 1158.87% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.5 million, marking a year-over-year increase of 3848.4%. This contributed to the annual value of -$20.9 million for FY2024, which is 3418.17% down from last year.
  • Latest data reveals that Bioharvest Sciences reported Operating Expenses of -$6.5 million as of Q3 2025, which was down 1158.87% from -$6.9 million recorded in Q2 2025.
  • Bioharvest Sciences' 5-year Operating Expenses high stood at $4.0 million for Q2 2023, and its period low was -$26.4 million during Q4 2023.
  • For the 3-year period, Bioharvest Sciences' Operating Expenses averaged around -$6.0 million, with its median value being -$5.8 million (2024).
  • Over the last 5 years, Bioharvest Sciences' Operating Expenses had its largest YoY gain of 7795.57% in 2024, and its largest YoY loss of 26862.86% in 2024.
  • Over the past 3 years, Bioharvest Sciences' Operating Expenses (Quarter) stood at -$26.4 million in 2023, then surged by 77.96% to -$5.8 million in 2024, then dropped by 11.7% to -$6.5 million in 2025.
  • Its Operating Expenses stands at -$6.5 million for Q3 2025, versus -$6.9 million for Q2 2025 and -$6.3 million for Q1 2025.